Yeast cell wall mannan rich fraction modulates bacterial cellular respiration potentiating antibiotic efficacy

• Published in: Scientific reports 2020-12, Vol.10 (1), p.21880-21880, Article 21880
• Main Authors: Smith, Helen, Grant, Sharon, Parker, Joanne, Murphy, Richard
• Format: Article
• Language: English
• Subjects: 631/326; 631/337; 631/80; Acidification; Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; Antibiotic resistance; Antibiotics; Antimicrobial resistance; Bacteria; Cell death; Cell Wall - chemistry; Cell walls; E coli; Energy metabolism; Energy output; Escherichia coli; Escherichia coli - growth & development; Humanities and Social Sciences; Mannan; Mannans - chemistry; Mannans - pharmacology; Metabolism; multidisciplinary; Oxygen consumption; Respiration; Saccharomyces cerevisiae - chemistry; Science; Science (multidisciplinary); Yeasts
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-78855-5

Now more than ever there is a demand to understand the mechanisms surrounding antibiotic resistance and look for alternative ways to impact phenotypic antibiotic outcome. Cellular energetics can be impacted by many bacteriostatic and bactericidal antibiotics, which affect metabolism and energy output, resulting in a reduction of cell growth or induction of cell death respectively. In this study, we provide evidence that a mannan rich fraction (MRF) from the cell wall of Saccharomyces cerevisiae modulates growth of antibiotic susceptible and resistant Escherichia coli and potentiates bactericidal antibiotic efficiency through modulation of bacterial cellular respiration. The role of MRF in modulating bactericidal impact and cellular metabolic state were assessed in E. coli by monitoring microbial growth and by measuring oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) using the Seahorse XFe96 Analyser, respectively. This work further illustrates the link between bacterial susceptibility to antibiotics (phenotypic resistance) and resistance through modulation of bacterial metabolism. This is the first example of yeast MRF enabling collateral sensitivity to antibiotics in vitro and supports the search for alternative strategies to promote animal health without contributing to the growing issue of antimicrobial resistance.